Search
30 Jul Diabetic Retinopathy May Impact Daily Work and Activities
MedicalResearch.com Interview with: Jeffrey R. Willis MD, PhD UC Davis Eye Center University of California, Davis Sacramento California MedicalResearch.com: What is the background for this study? What are the main findings? Response: Diabetic retinopathy is one of the leading causes of blindness in the United States. Yet there is limited...25 Jul Unregulated Direct-to-Consumer Treatment Centers Provide Stem Cells for Patients With Heart Failure
MedicalResearch.com Interview with: Dr. Paul J. Hauptman, MD Professor of Internal Medicine Division of Cardiology Assistant Dean, Clinical and Translational Research Saint Louis University School of Medicine St. Louis MO 63110-0250 MedicalResearch.com: What is the background for this study? What are the main findings? Response: A publication in 2016 by Leigh...21 Jul Drugs That Target Th17 Cells Can Improve Debilitating Skin Disease Hidradenitis suppurativa
MedicalResearch.com Interview with: Dr Jean Fletcher Assistant Professor Schools of Medicine and Biochemistry & Immunology Trinity College Dublin, the University of Dublin Dublin, Ireland MedicalResearch.com: What is the background for this study? What are the main findings? Response: Hidradenitis suppurativa (HS) is an inflammatory skin disease which causes deep, painful...21 Jul Erectile Dysfunction Should Be a Marker For Diabetes
MedicalResearch.com Interview with: Damiano Pizzol Operational Research Unit, Doctors with Africa Cuamm Beira, Mozambique MedicalResearch.com: What is the background for this study? Response: Since the 1970s the association between diabetes and the development of erectile dysfunction has been documented both in animal models and humans Several studies have considered the...19 Jul Targeting CD44s May Make Glioblastoma More Sensitive To Clinical Treatment
Posted at 15:20h
in Author Interviews, Baylor College of Medicine Houston, Biomarkers, Brain Cancer - Brain Tumors, Cancer Research, PNAS
MedicalResearch.com Interview with: Chonghui Cheng, M.D., Ph.D. Associate Professor Department of Molecular & Human Genetics Lester & Sue Smith Breast Center Baylor College of Medicine Houston, TX77030 MedicalResearch.com: What is the background for this study? What are the main findings? Response: Understanding the mechanisms that give cancer cells the ability to...
17 Jul Primary Care Practice Interventions Helped Maintain Adherence to Opioid Prescription Guidelines
MedicalResearch.com Interview with: Jane M. Liebschutz, MD, MPH Associate Professor of Medicine Section of General Internal Medicine Boston University School of Medicine Boston, Massachusetts MedicalResearch.com: What is the background for this study? Response: The number of patients receiving opioids for chronic pain has risen over the past 2 decades in the US,...10 Jul Optimistic Results From Phase 3 Study of RBP-6000 Buprenorphine Monthly Depot for Treatment of Opioid Use Disorder
Medical Research.com Interview with: Dr. Christian Heidbreder, PhD Chief Scientific Officer Indivior Inc. Richmond, VA 23235, USA MedicalResearch.com: What is the background for this study? What are the main findings? Response: This pivotal Phase 3 clinical trial (RB-US-13-0001) evaluated the efficacy and safety of RBP-6000, an investigational once-monthly injectable buprenorphine...07 Jul Clinical Perineural Invasion of Cutaneous SCC May Warrant Adjuvant Treatment
Posted at 17:54h
in Author Interviews, Brigham & Women's - Harvard, Cancer Research, Dermatology, JAMA
MedicalResearch.com Interview with: Dr. Chrysalyne D. Schmults, MD, MSCE Associate Professor of Dermatology, Harvard Medical School Director, Mohs and Dermatologic Surgery Center and Mr. Pritesh S. Karia, MPH Department of Epidemiology Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland Department of Dermatology Brigham and Women’s Faulkner Hospital Harvard Medical School, Boston,...
07 Jul Eyedrop Kallikrein Inhibitor Shows Promise for Diabetic Macular Edema
MedicalResearch.com Interview with: Dr. David Kita, PhD Founder and Head of R&D Verseon Corporation MedicalResearch.com: What is the background for this study? Dr. Kita: The preclinical data presented at the 2017 BIO International Conference provided details about Verseon’s plasma kallikrein inhibitors for the treatment of diabetic macular edema (DME). DME...06 Jul RNA Splicing Variants Linked To Aggressive Prostate Cancer in African Americans
MedicalResearch.com Interview with: Dr. Norman Lee PhD Professor of Pharmacology and Physiology School of Medicine and Health Sciences George Washington University MedicalResearch.com: What is the background for this study? What are the main findings? Response: There are health disparities when it comes to prostate cancer. The African American population, in...05 Jul Transgender Actors Effective in Teaching Residents to Provide Respectful and Effective Health Care
MedicalResearch.com Interview with: Richard E. Greene, MD, FACP Medical Director, Bellevue Adult Primary Care Center Assistant Professor, NYU School of Medicine Associate Program Director, Primary Care Residency Program Director, Gender and Health Education, Office of Diversity Affairs, NYU School of Medicine, OUTList Medical Director, CHIBPS, The Center for Health, Identity, Behavior and Prevention Studies VP...04 Jul Vitamin A Derivative May Have Anti-Diabetic Capabilities
MedicalResearch.com Interview with: Stefan Amisten, PhD The Oxford Centre for Diabetes, Endocrinology & Metabolism University of Oxford, Oxford Diabetes Research Group, Division of Diabetes & Nutritional Sciences King’s College London, Faculty of Life Sciences & Medicine, London UK MedicalResearch.com: What is the background for this study? Response: Type 2 diabetes...22 Jun Animal Visitation Programs Can Raise Infection Risks In Health Care Facilities
MedicalResearch.com Interview with: Deborah Linder, DVM, MS, DACVN Research assistant professor Cummings School of Veterinary Medicine Tufts University and Associate director of the Tufts Institute for Human-Animal Interaction MedicalResearch.com: What is the background for this study? Response: In our experience with our own therapy animal program, Tufts Paws for People,...22 Jun PCSK9 Inhibitor Praluent Added to Statins Improved Lipid Profile in Diabetes
MedicalResearch.com Interview with: Robert R. Henry, M.D. Professor of Medicine Member of the ODYSSEY DM Steering Committee and Director of the Center for Metabolic Research VA San Diego Healthcare System MedicalResearch.com: What is the background for this study? What are the main findings? Response: The ODYSSEY DM-DYSLIPIDEMIA trial was a...21 Jun How Do We Retrieve Speech From Our 50,000 Word Mental Dictionary?
Posted at 23:18h
in Author Interviews
MedicalResearch.com Interview with: Stephanie Ries, PhD Assistant Professor School of Speech, Language, and Hearing Sciences Center for Clinical and Cognitive Neuroscience San Diego State University Director of the Laboratory for the Brain Dynamics of Language San Diego, CA MedicalResearch.com: What is the background for this study? What are the main...
19 Jun The President’s Malaria Initiative Reduced All-Cause Childhood Mortality
MedicalResearch.com Interview with: Aleksandra Jakubowski, MPH PhD candidate Department of Health Policy and Management Gillings School of Global Public Health University of North Carolina at Chapel Hill MedicalResearch.com: What is the background for this study? Response: The US President’s Malaria Initiative (PMI) provides approximately $600 million annually to fund implementation...19 Jun Adding Praluent (Alirocumab) To Statins Reduces LDL in High Cardiovascular Risk Diabetics
Posted at 20:19h
in AstraZeneca, Author Interviews, Boehringer Ingelheim, Diabetes, Eli Lilly, J&J-Janssen, Lipids, Merck
MedicalResearch.com Interview with: Lawrence Leiter, M.D. MDCM, FRCPC, FACP FACE, FAHA Chair of the ODYSSEY DM Steering Committee and Director of the Lipid Clinic at the Li Ka Shing Knowledge Institute St. Michael’s Hospital University of Toronto, Canada MedicalResearch.com: What is the background for this study? What are the main findings?...
13 Jun Comprehensive Study of Metabolic Inhibitors Reveals the Anti-Tumor Efficacy of Phenformin in Pancreatic Cancer
MedicalResearch.com Interview with: Rajesh Kumar NV, Ph.D. Instructor of Oncology and Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, USA Current affiliation Senior Manager, Human Therapeutics Division, Intrexon Corporation Germantown, MD MedicalResearch.com: What is the background for this study? Response: Pancreatic ductal adenocarcinoma (a.k.a. pancreatic cancer) is one of...13 Jun Oral Sotagliflozin On Top of Optimized Insulin Significantly Reduced A1C
MedicalResearch.com Interview with: Prof. Dr. Thomas Danne Chief Physician Diabetology, Endocrinology and General Pediatrics and Clinical Researc Kinder und Junden Krankenhaus MedicalResearch.com: What is the background for this study? What are the main findings? Response: The double-blind, placebo controlled, Phase 3 study known as inTandem2 randomized 782 adult patients from...13 Jun Letermovir Found Highly Effective In Preventing CMV Infection
MedicalResearch.com Interview with: Roy F Chemaly, M.D., M.P.H., F.A.C.P., F.I.D.S.A Professor, Department of Infectious Diseases, Director, Infection Control and Employee Health, Division of Internal Medicine Director of the clinical virology research program,Department of infectious diseases Infection control and employee health The University of Texas MD Anderson MedicalResearch.com: Would you briefly...10 Jun Home Finger Stick Testing Provided No Health Advantage in Study of Type 2 Diabetics
MedicalResearch.com Interview with: Katrina Donahue MD, MPH Professor, Director of Research, UNC Family Medicine. Co-Director, North Carolina Newtork Consortium (NCNC). Chapel Hill, NC MedicalResearch.com: What is the background for this study? Response: Type 2 diabetes is an epidemic affecting one in 11 people in the United States. For those treated...09 Jun Functional Brain Markers Can Suggest Susceptibility to PTSD
MedicalResearch.com Interview with: Jennifer Stevens, PhD Director, Neuroscience of Memory, Emotion, and Stress Laboratory Instructor, Dept of Psychiatry & Behavioral Sciences Emory University School of Medicine MedicalResearch.com: What is the background for this study? Response: Post-traumatic stress disorder (PTSD) was once thought to be a disorder of combat veterans, however,...05 Jun Merkel Cell Carcinoma: Promising Treatment With Combination of T cells and PD-1 Blockade
MedicalResearch.com Interview with: Dr. Kelly Garneski Paulson, MD, PHD Fred Hutchinson Cancer Research Center Seattle, WA MedicalResearch.com: What is the background for this study? What are the main findings? Response: Merkel cell carcinoma (MCC) is an aggressive skin cancer with increasing impact. Currently, there are more than 2000 new cases...05 Jun Herceptin Biosimilar CT-P6 Found Safe and Effective in Early Breast Cancer
MedicalResearch.com Interview with: Prof Francisco J Esteva MD PhD Director of the breast medical oncology program at Perlmutter Cancer Center. NYU Langone Medical Center MedicalResearch.com: What is the background for this study? What are the main findings? Response: Trastuzumab is a monoclonal antibody directed against the human epidermal growth factor...01 Jun White Blood Cells Reprogrammed To Promote Wound Healing
MedicalResearch.com Interview with: Jean-François Cailhier, M.D., Ph.D., FRCP(c) Professeur Agrégé de Clinique/ Associate Professor Département de Médecine, Faculté de Médecine Université de Montreal MedicalResearch.com: What is the background for this study? What are the main findings? Response: Milk Fat Globule Epidermal Growth Factor-8 (MFG-E8) is released by apoptotic cells and...01 Jun High Hepatitis C Cure Rate Using Elbasvir plus Grazoprevir In Chronic Kidney Disease
MedicalResearch.com Interview with: Annette Bruchfeld MD, PhD Senior Consultant Associate Professor Karolinska Institute Dept of Renal Medicine, M99 Karolinska University Hospital Huddinge Stockholm, Sweden MedicalResearch.com: What is the background for this study? What are the main findings? Response: In patients with stage 4–5 chronic kidney disease(CKD), hepatitis C virus (HCV)...27 May LATUDA Phase 3 Study Demonstrates Improvement in Pediatric and Adolescent Bipolar Depression
MedicalResearch.com Interview with: Antony Loebel, M.D. Executive Vice President and Chief Medical Officer Sunovion, Head of Global Clinical Development Sumitomo Dainippon Pharma Group MedicalResearch.com: What is the background for this study? What are the main findings? In the six-week, randomized, double-blind, placebo-controlled study, 347 children and adolescents (10 to 17...13 May Improving Statin Adherence Would Reduce Need For Expensive PCSK9 Inhibitors
Posted at 01:15h
in AHA Journals, Author Interviews, Baylor College of Medicine Houston, Heart Disease, Lipids
MedicalResearch.com Interview with: Julia M. Akeroyd, MPH Center for Innovations in Quality, Effectiveness, and Safety (IQuESt) Michael E. DeBakey Veteran Affairs Medical Center Salim S Virani, MBBS, Ph.D. Baylor College of Medicine MedicalResearch.com: What is the background for this study? Response: In the recently published Further Cardiovascular Outcomes Research with...